Theravance Cash from Investing TTM:
-111.68M for March 31, 2013Theravance Historical Cash from Investing TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -111.68M |
| Dec. 31, 2012 | -58.28M |
| Sept. 30, 2012 | -53.88M |
| June 30, 2012 | -30.07M |
| March 31, 2012 | -46.20M |
| Dec. 31, 2011 | -55.82M |
| Sept. 30, 2011 | -78.40M |
| June 30, 2011 | -57.31M |
| March 31, 2011 | -33.57M |
| Dec. 31, 2010 | -40.31M |
| Sept. 30, 2010 | -41.75M |
| June 30, 2010 | -27.60M |
| March 31, 2010 | -8.78M |
| Dec. 31, 2009 | 1.736M |
| Sept. 30, 2009 | 3.426M |
| June 30, 2009 | 32.72M |
| March 31, 2009 | 71.44M |
| Dec. 31, 2008 | -67.37M |
| Sept. 30, 2008 | -8.496M |
| June 30, 2008 | -21.38M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
About Cash From Investing (TTM)
THRX Cash from Investing TTM Benchmarks
| Companies | |
|---|---|
| Elan | 65.80M |
| GlaxoSmithKline | -4.923B |
| Athersys | 3.89M |
THRX Cash from Investing TTM Rankings
| Overall |
56th percentile 3326 of 7590 |
| Sector |
25th percentile 484 of 651 in Healthcare |
| Industry |
19th percentile 191 of 237 in Biotechnology |
THRX Cash from Investing TTM Range, Past 5 Years
| Minimum | -111.68M | Mar 2013 |
| Maximum | 71.44M | Mar 2009 |
| Average | -31.58M |
